Cargando…

Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk

To identify novel risk variants for chronic lymphocytic leukemia (CLL) we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls. We identified four risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Crowther-Swanepoel, Dalemari, Broderick, Peter, Di Bernardo, Maria Chiara, Dobbins, Sara E, Torres, María, Mansouri, Mahmoud, Ruiz-Ponte, Clara, Enjuanes, Anna, Rosenquist, Richard, Carracedo, Angel, Jurlander, Jesper, Campo, Elias, Juliusson, Gunnar, Montserrat, Emilio, Smedby, Karin E, Dyer, Martin JS, Matutes, Estella, Dearden, Claire, Sunter, Nicola J, Hall, Andrew G, Mainou-Fowler, Tryfonia, Jackson, Graham H, Summerfield, Geoffrey, Harris, Robert J, Pettitt, Andrew R, Allsup, David J, Bailey, James R, Pratt, Guy, Pepper, Chris, Fegan, Chris, Parker, Anton, Oscier, David, Allan, James M, Catovsky, Daniel, Houlston, Richard S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321238/
https://www.ncbi.nlm.nih.gov/pubmed/20062064
http://dx.doi.org/10.1038/ng.510
_version_ 1782509655927291904
author Crowther-Swanepoel, Dalemari
Broderick, Peter
Di Bernardo, Maria Chiara
Dobbins, Sara E
Torres, María
Mansouri, Mahmoud
Ruiz-Ponte, Clara
Enjuanes, Anna
Rosenquist, Richard
Carracedo, Angel
Jurlander, Jesper
Campo, Elias
Juliusson, Gunnar
Montserrat, Emilio
Smedby, Karin E
Dyer, Martin JS
Matutes, Estella
Dearden, Claire
Sunter, Nicola J
Hall, Andrew G
Mainou-Fowler, Tryfonia
Jackson, Graham H
Summerfield, Geoffrey
Harris, Robert J
Pettitt, Andrew R
Allsup, David J
Bailey, James R
Pratt, Guy
Pepper, Chris
Fegan, Chris
Parker, Anton
Oscier, David
Allan, James M
Catovsky, Daniel
Houlston, Richard S
author_facet Crowther-Swanepoel, Dalemari
Broderick, Peter
Di Bernardo, Maria Chiara
Dobbins, Sara E
Torres, María
Mansouri, Mahmoud
Ruiz-Ponte, Clara
Enjuanes, Anna
Rosenquist, Richard
Carracedo, Angel
Jurlander, Jesper
Campo, Elias
Juliusson, Gunnar
Montserrat, Emilio
Smedby, Karin E
Dyer, Martin JS
Matutes, Estella
Dearden, Claire
Sunter, Nicola J
Hall, Andrew G
Mainou-Fowler, Tryfonia
Jackson, Graham H
Summerfield, Geoffrey
Harris, Robert J
Pettitt, Andrew R
Allsup, David J
Bailey, James R
Pratt, Guy
Pepper, Chris
Fegan, Chris
Parker, Anton
Oscier, David
Allan, James M
Catovsky, Daniel
Houlston, Richard S
author_sort Crowther-Swanepoel, Dalemari
collection PubMed
description To identify novel risk variants for chronic lymphocytic leukemia (CLL) we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls. We identified four risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio [OR] = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)). There was also evidence for risk loci at 15q25.2 (rs783540, CPEB1; OR = 1.18; P = 3.67 x 10(-6)) and 18q21.1 (rs1036935; OR = 1.22; P = 2.28 x 10(-6)). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy.
format Online
Article
Text
id pubmed-5321238
institution National Center for Biotechnology Information
language English
publishDate 2010
record_format MEDLINE/PubMed
spelling pubmed-53212382017-02-22 Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk Crowther-Swanepoel, Dalemari Broderick, Peter Di Bernardo, Maria Chiara Dobbins, Sara E Torres, María Mansouri, Mahmoud Ruiz-Ponte, Clara Enjuanes, Anna Rosenquist, Richard Carracedo, Angel Jurlander, Jesper Campo, Elias Juliusson, Gunnar Montserrat, Emilio Smedby, Karin E Dyer, Martin JS Matutes, Estella Dearden, Claire Sunter, Nicola J Hall, Andrew G Mainou-Fowler, Tryfonia Jackson, Graham H Summerfield, Geoffrey Harris, Robert J Pettitt, Andrew R Allsup, David J Bailey, James R Pratt, Guy Pepper, Chris Fegan, Chris Parker, Anton Oscier, David Allan, James M Catovsky, Daniel Houlston, Richard S Nat Genet Article To identify novel risk variants for chronic lymphocytic leukemia (CLL) we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls. We identified four risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio [OR] = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)). There was also evidence for risk loci at 15q25.2 (rs783540, CPEB1; OR = 1.18; P = 3.67 x 10(-6)) and 18q21.1 (rs1036935; OR = 1.22; P = 2.28 x 10(-6)). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy. 2010-01-10 2010-02 /pmc/articles/PMC5321238/ /pubmed/20062064 http://dx.doi.org/10.1038/ng.510 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Crowther-Swanepoel, Dalemari
Broderick, Peter
Di Bernardo, Maria Chiara
Dobbins, Sara E
Torres, María
Mansouri, Mahmoud
Ruiz-Ponte, Clara
Enjuanes, Anna
Rosenquist, Richard
Carracedo, Angel
Jurlander, Jesper
Campo, Elias
Juliusson, Gunnar
Montserrat, Emilio
Smedby, Karin E
Dyer, Martin JS
Matutes, Estella
Dearden, Claire
Sunter, Nicola J
Hall, Andrew G
Mainou-Fowler, Tryfonia
Jackson, Graham H
Summerfield, Geoffrey
Harris, Robert J
Pettitt, Andrew R
Allsup, David J
Bailey, James R
Pratt, Guy
Pepper, Chris
Fegan, Chris
Parker, Anton
Oscier, David
Allan, James M
Catovsky, Daniel
Houlston, Richard S
Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
title Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
title_full Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
title_fullStr Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
title_full_unstemmed Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
title_short Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
title_sort common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321238/
https://www.ncbi.nlm.nih.gov/pubmed/20062064
http://dx.doi.org/10.1038/ng.510
work_keys_str_mv AT crowtherswanepoeldalemari commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT broderickpeter commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT dibernardomariachiara commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT dobbinssarae commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT torresmaria commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT mansourimahmoud commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT ruizponteclara commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT enjuanesanna commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT rosenquistrichard commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT carracedoangel commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT jurlanderjesper commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT campoelias commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT juliussongunnar commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT montserratemilio commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT smedbykarine commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT dyermartinjs commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT matutesestella commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT deardenclaire commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT sunternicolaj commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT hallandrewg commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT mainoufowlertryfonia commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT jacksongrahamh commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT summerfieldgeoffrey commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT harrisrobertj commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT pettittandrewr commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT allsupdavidj commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT baileyjamesr commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT prattguy commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT pepperchris commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT feganchris commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT parkeranton commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT oscierdavid commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT allanjamesm commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT catovskydaniel commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk
AT houlstonrichards commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk